AI Image
Father of 4 says GLP-1 shots left him blind
WSB-TV • • business
Key Points:
- New complaints have emerged linking GLP-1 weight loss drugs, such as Ozempic, to cases of blindness caused by NAION, an eye stroke condition.
- Ed Gillen, a user of the drug, experienced sudden vision loss and now requires a walking stick, highlighting the severe impact of this side effect.
- Several individuals, including Gillen and Diane Wirth, have filed lawsuits against the drug maker Novo Nordisk, alleging failure to warn about the risk of vision loss.
- Novo Nordisk maintains that its studies found no increased risk of blindness, but multiple lawsuits are pending in Philadelphia, accusing the company of a lack of transparency.
- Investigative news outlets continue to follow the story, noting that legal proceedings may take years to resolve.
